Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man.
Serial serum diphenylhydantoin and urinary 5-(p-hydroxphenyl)-5-phenylhydantoin concentrations were determined in 8 patients with malignant disease and 4 healthy volunteers on 2 separate occasions after an oral dose of diphenylhydantoin (500 mg). No significant difference was observed between metabolism before and 10 days after immunization with BCG or Corynebacterium parvum. Volunteers without intervening immunization similarly showed no difference.
D000230:Adenocarcinoma / Q000378:metabolism; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000494:pharmacology*; D001428:Bacterial Vaccines / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D008545:Melanoma / Q000378:metabolism; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010672:Phenytoin / Q000378:metabolism*; D011425:Propionibacterium acnes / Q000276:immunology*; D012004:Rectal Neoplasms / Q000378:metabolism
D001500:BCG Vaccine; D001428:Bacterial Vaccines; D010672:Phenytoin